Flow cytometry analysis of tumors excised from the mice at the end of treatment revealed that the populations of tumor-infiltrated CD45+CD8+ T-cells and CD45+CD4+ T-cells increased after Itga2 knockdown, while the population of CD11b+Gr1+ myeloid cells decreased (Fig. 7f). The gene discussed is ITGA2; the disease is neoplasm.